Wegovy costs $1,349/mo retail.
Compounded from $35/mo.
Median monthly program price across 528 listed clinics that publish rates: $199/mo. Calculate your true out-of-pocket cost, compare telehealth vs in-person care, and see the pathways that actually move the price (insurance, prior auth, manufacturer programs).
Last updated July 2026 · TrimSoMo Editorial Team
This page covers Wegovy pricing. For the full brand overview — providers, dosing, and alternatives — see the Wegovy brand guide, or find clinics near you.
Price Distribution
How prices vary across telehealth, in-person, brand-name, and compounded options.
Ways to Save
Compounded semaglutide and tirzepatide is not FDA-approved. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality. Across 2025–2026 the FDA restricted compounding of these medicines to documented medical need through state-licensed 503A / 503B pharmacies, and has warned about fraudulent and counterfeit compounded GLP-1 products.
FDA references: human drug compounding policy (FDA, April 2026 update) · warning on fraudulent compounded GLP-1 products (FDA, June 2026). This is factual information, not medical advice — confirm current legality and your own eligibility with a licensed clinician.
Cost Estimator
Get a rough monthly cost estimate for your situation.
Pricing seeded from 528 listed clinics that publish their rates.
Wegovy Cost — Frequently Asked Questions
How much does Wegovy cost without insurance in 2026?
Brand Wegovy runs roughly $1,000–$1,350/mo at cash retail. Telehealth programs commonly cost $249–$599/mo, and compounded alternatives (where medically appropriate) start near $179/mo. Median program price across our sources is about $199/mo.
What is the cheapest way to get Wegovy?
The lowest-cost routes are insurance with prior authorization, manufacturer savings/patient-assistance programs, telehealth bulk pricing, and 503A/503B compounded alternatives. Our cost calculator estimates your true out-of-pocket by route.
Does insurance cover Wegovy?
Many plans cover GLP-1 medications with prior authorization when BMI ≥ 30 (or ≥ 27 with a weight-related condition). Coverage and copays vary widely by plan and employer.
Related guides
The BMI thresholds for Wegovy, Zepbound and compounded GLP-1 in 2026 — what the FDA, insurance plans, and telehealth clinics each require, and the exceptions that get borderline patients approved.
A plain-English breakdown of Wegovy's cash price, why telehealth programs are cheaper, and how compounded semaglutide compares — with the questions to ask before you pay.
Oral GLP-1 weight-loss options are changing the market. Here's how oral semaglutide works, what to verify about cash pricing, the empty-stomach catch, and whether to discuss switching from injections.
How Wegovy (semaglutide) and Zepbound (tirzepatide) differ on mechanism, average weight loss, side effects, and cost — so you can have a smarter conversation with your provider.
Wegovy, Zepbound and Ozempic pricing is shifting in 2026 through manufacturer cash-pay channels, direct-to-consumer programs, and insurance rule changes. A practical map of options to verify.
After the FDA declared the semaglutide shortage over, the rules for compounded GLP-1s changed. Here's what's actually allowed in 2026, why your cheap compounded program may have stopped, and how to stay safe.